Is This Fast-Growing Dividend Stock a Buy?
Buying companies that steadily grow their revenue and earnings at reasonable valuations is the key to success as a long-term investor.
Despite its $119 billion market capitalization and status as the world's third-largest publicly traded health insurer, Anthem (NYSE: ANTM) still has plenty of growth left in its future. But is the stock a buy? Let's dig into Anthem's fundamentals and valuation to find out.
On April 20, Anthem reported excellent first-quarter earnings results.
Source Fool.com
